David Fitzgerald

Dr. David Fitzgerald

Laboratory of Molecular Biology, CCR, NCI, NIH, HHS, 37 Convent Dr, Room 5124, Bethesda, MD, 20892, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PWPaula J. Wilderman
Paula J. Wilderman
NSNathaniel A. Sowa
Nathaniel A. Sowa
David FitzgeraldDavid Fitzgerald
David Fitzgerald
PFPeter C. FitzGerald
Peter C. FitzGerald
SGSusan Gottesman
Susan Gottesman
MVMichael L. Vasil
Michael L. Vasil
In many bacteria, iron homeostasis is controlled primarily by the ferric uptake regulator (Fur), a transcriptional repressor. However, some genes, including those involved in iron storage, are positively regulated by Fur. A Fur-repressed regulatory small RNA (sRNA), RyhB, has been identified in Escherichia coli , and it has been demonstrated that negative regulation of genes by this sRNA is responsible for the positive regulation of some genes by Fur. No RyhB sequence homologs were found in Pseudomonas aeruginosa , despite the identification of genes positively regulated by its Fur homolog. A bioinformatics approach identified two tandem sRNAs in P. aeruginosa that were candidates for functional homologs of RyhB. These sRNAs (PrrF1 and PrrF2) are >95% identical to each other, and a functional Fur box precedes each. Their expression is induced under iron limitation. Deletion of both sRNAs is required to affect the iron-dependent regulation of an array of genes, including those involved in resistance to oxidative stress, iron storage, and intermediary metabolism. As in E. coli , induction of the PrrF sRNAs leads to the rapid loss of mRNAs for sodB (superoxide dismutase), sdh (succinate dehydrogenase), and a gene encoding a bacterioferritin. Thus, the PrrF sRNAs are the functional homologs of RyhB sRNA. At least one gene, bfrB , is positively regulated by Fur and Fe 2+ , even in the absence of the PrrF sRNAs. This work suggests that the role of sRNAs in bacterial iron homeostasis may be broad, and approaches similar to those described here may identify these sRNAs in other organisms.

1 January 2004 in International Journal of Medical Microbiology
Verified
Journal Article
Closed access
David FitzgeraldDavid Fitzgerald
David Fitzgerald
RKRobert Kreitman
Robert Kreitman
WWWyndham Wilson
Wyndham Wilson
DSDavid Squires
David Squires
IPIra Pastan
Ira Pastan

1 July 2010 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
RTRoberta Traini
Roberta Traini
GBGal Ben-Josef
Gal Ben-Josef
DPDiana V. Pastrana
Diana V. Pastrana
EMElizabeth Moskatel
Elizabeth Moskatel
ASAshima K. Sharma
Ashima K. Sharma
David FitzgeraldDavid Fitzgerald
David Fitzgerald
Pseudomonas exotoxin (PE)–based immunotoxins (antibody-toxin fusion proteins) have achieved frequent complete remissions in patients with hairy cell leukemia but far fewer objective responses in other cancers. To address possible mechanisms of resistance, we investigated immunotoxin activity in a model system using the colon cancer cell line, DLD1. Despite causing complete inhibition of protein synthesis, there was no evidence that an immunotoxin targeted to the transferrin receptor caused apoptosis in these cells. To address a possible protective role of prosurvival Bcl-2 proteins, the BH3-only mimetic, ABT-737, was tested alone or in combination with immunotoxins. Neither the immunotoxin nor ABT-737 alone activated caspase 3, whereas the combination exhibited substantial activation. In other epithelial cell lines, ABT-737 enhanced the cytotoxicity of PE-related immunotoxins by as much as 20-fold, but did not enhance diphtheria toxin or cycloheximide. Because PE translocates to the cytosol via the endoplasmic reticulum (ER) and the other toxins do not, ABT-737–mediated effects on the ER were investigated. ABT-737 treatment stimulated increased levels of ER stress response factor, ATF4. Because of its activity in the ER, ABT-737 might be particularly well suited for enhancing the activity of immunotoxins that translocate from the ER to the cell cytosol. Mol Cancer Ther; 9(7); 2007–15. ©2010 AACR.

23 July 2012 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
AMAbid R. Mattoo
Abid R. Mattoo
David FitzgeraldDavid Fitzgerald
David Fitzgerald
Synergistic killing was achieved when Small Cell Lung Cancer (SCLC) cell lines were incubated with ABT‐263 and an immunotoxin directed to the transferrin receptor. SCLC lines are variably sensitive to the BH‐3 only peptide mimetic, ABT‐263. To determine their sensitivity to toxin‐based reagents, we incubated four representative SCLC lines with a model Pseudomonas exotoxin‐based immunotoxin directed to the transferrin receptor. Remarkably in 4‐of‐4 lines, there was little evidence of immunotoxin‐mediated cytotoxicity despite near complete inhibition of protein synthesis. However, when combinations of ABT‐263 and immunotoxin were added to the ABT‐263‐resistant cell lines (H196 and H69AR), there was synergistic killing as evidenced by increased activation of caspase 3/7, annexin V staining, and loss of cell integrity. Synergistic killing was evident at 6 hr and correlated with loss of Mcl‐1. This synergy was also noted when the closely related compound ABT‐737 was combined with the same immunotoxin. To establish that the synergy seen in tissue culture could be achieved in vivo , H69AR cells were grown as tumors in nude mice and shown to be susceptible to the killing action of an immunotoxin‐ABT‐737 combination but not to either agent alone. When immunotoxin‐ABT combinations were added to ABT‐263‐sensitive lines (H146 and H1417), killing was additive. Our data support combination approaches for treating ABT‐263‐resistant SCLC with ABT‐263 and a second agent that provides synergistic killing action.

1 November 2001 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
RHRalf Hertle
Ralf Hertle
RMRandall Mrsny
Randall Mrsny
David FitzgeraldDavid Fitzgerald
David Fitzgerald
Pseudomonas aeruginosa is the major infectious agent of concern for cystic fibrosis patients. Strategies to prevent colonization by this bacterium and/or neutralize its virulence factors are clearly needed. Here we characterize a dual-function vaccine designed to generate antibodies to reduce bacterial adherence and to neutralize the cytotoxic activity of exotoxin A. To construct the vaccine, key sequences from type IV pilin were inserted into a vector encoding a nontoxic (active-site deletion) version of exotoxin A. The chimeric protein, termed PE64Δ553pil, was expressed in Escherichia coli , refolded to a near-native conformation, and then characterized by various biochemical and immunological assays. PE64Δ553pil bound specifically to asialo-GM1, and, when injected into rabbits, produced antibodies that reduced bacterial adherence and neutralized the cell-killing activity of exotoxin A. Results support further evaluation of this chimeric protein as a vaccine to prevent Pseudomonas colonization in susceptible individuals.

1 April 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RSRobert Sarnovsky
Robert Sarnovsky
JRJennifer Rea
Jennifer Rea
MMMatt Makowski
Matt Makowski
RHRalf Hertle
Ralf Hertle
CKColleen Kelly
Colleen Kelly
David FitzgeraldDavid Fitzgerald
David Fitzgerald
At high bacterial cell density the gene expression program of Pseudomonas aeruginosa is regulated by quorum sensing. Among the gene products highly up-regulated by this system is an exoprotease, leucine aminopeptidase (PA-LAP), which is coexpressed with several known virulence factors and secreted as a proenzyme. We undertook a study of its activation by expressing the full-length proform of PA-LAP recombinantly in Escherichia coli (here termed, rLAP55) and characterizing individual steps in its conversion to an active enzyme. Activation is initiated with the proteolytic removal of a C-terminal prosequence. Removal of ∼20 amino acids is accomplished by Pseudomonas elastase, which is also positively regulated by quorum sensing. Activation is also mediated by other proteases that cleave rLAP55 near its C terminus. The importance of the C terminus was confirmed by showing that C-terminal deletions of 1-24 amino acids produce a fully active enzyme. The removal of C-terminal prosequences either by proteolysis or deletion leads to an unusual autoprocessing event at the N terminus. Autoprocessing is apparently an intramolecular event, requires the active site of LAP, and results in the removal of 12 N-terminal amino acids. Furthermore, a detailed analysis of the C-terminal prosequence suggests that the proenzyme state is dependent on the presence of a basic side chain contributed by the last amino acid, lysine 536. Our data support a model whereby full-length PA-LAP is activated in a two-step process; proteolytic cleavage at the C terminus is followed by an intramolecular autocatalytic removal of a 12-amino acid propeptide at the N terminus.